DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...

cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields The disruptive, proprietary technology developed by EVerZom offers a ...

Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

The university plays a vital role in addressing social challenges and improving quality of life. Its success is built on five dynamic institutes specializing in chemistry and biotechnology, food and ...

T cell lymphocytes play a central role in the adaptive immune response. They are an essential tool of adoptive cell therapy for the treatment of chronic viral infections and malignant diseases.

To test their setup, researchers allowed algae cells to stick to the surface of the photobioreactor. When they applied a voltage, the bubbles separated the cells from the surfaces without harming them ...

While Fujifilm Diosynth Biotechnologies isn’t immune to the challenges facing the broader CDMO industry, the company’s long-running expansion journey—and its ability to snare high-profile pharma ...

Bioreactor makers should consider using additive manufacturing, also known as 3D printing, according to a study, which suggests the potential benefits of the approach would be worth the investment.

Bioreactors have become irreplaceable tools in bioprocessing, revolutionizing the production of many biotechnological products. 1,2 They offer optimized and controlled environments to enhance cell ...